Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Expert Insights on Generics and Biosimilars

With health reform on the horizon, generics and biosimilars are at the forefront of the discussion. Will the US establish a pathway for these drugs? What are the hurdles?

Get expert insights on:

  • Future role of generic companies as pharma faces unprecedented patent expiration on blockbuster compounds
  • Manufacturing and regulatory hurdles for biosimilars
  • Role of CROs in the generics industry
  • Competitive pressure from generic manufacturers in India and China
Engage an Expert on Generics and Biosimilars

Gerson Lehrman Group Council Members are available to discuss Generics and Biosimilars via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Joe Renner, CEO and part owner, ZYDUS PHARMACEUTICALS USA INC

Joe RennerWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

CEO and part ownerZYDUS PHARMACEUTICALS USA INC

Michael Malecki, Product Manager, DECISION RESOURCES, INC.

Michael MaleckiWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Product ManagerDECISION RESOURCES, INC.

Nicole Westphal, Product Manager, DECISION RESOURCES, INC.

Nicole WestphalWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Product ManagerDECISION RESOURCES, INC.

Bret Koplow, Partner, Head of Food & Drug Practice, SONNENSCHEIN, NATH & ROSENTHAL, LLP

Bret KoplowWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Partner, Head of Food & Drug PracticeSONNENSCHEIN, NATH & ROSENTHAL, LLP

Jeff Stier, Associate Director, American Council on Science and Health

Jeff StierWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Associate DirectorAmerican Council on Science and Health

Browse all 424 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Political Experts (outside Washington DC) 711
U.S. Department of Agriculture Experts: Legal, Economic, and Regulatory Affairs 28
Neurologists 1861
Neurologists (US) 1079
Neurologists who Treat Neuromuscular Disorders (US) 235

Browse all 974 Study Groups

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

2 generic drugs - Imitrex and Eloxatin

August 16, 2009

GLG Expert Contributor

Browse all 7849 GLG News Analyses

Contact Gerson Lehrman Group to engage a Generics and Biosimilars expert